Ventilation With ASV Mode in Children

December 12, 2023 updated by: FERRY Thomas, University of Lausanne Hospitals

Monocentric Interventional Study on the Feasibility of the Invasive Mechanical Ventilation Mode "Adaptive Support Ventilation, ASV" in a Pediatric Population and Comparison to Pressure-Control and Pressure-Support Ventilation Modes

ASV mode of ventilation is an automatic mode with closed-loop control used for mechanical invasive ventilation in intubated patients. It has been studied in adult patients but not in children.

This interventional physiology study will include 40 children on mechanical invasive ventilation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The objective of the study is to assess the feasibility of ASV in children and compare physiologic values on ASV mode to Pressure-Control and Pressure-Support mode of ventilation regarding the participant is on active or passive ventilation phase.

Physiologic values will be monitored on different modes of ventilation in a randomized order. Each participant will be his own control regarding the different modes of ventilation. Monitoring will be done during 90 minutes for each mode of ventilation.

Participant will have two different phases of ventilation. The first one is the passive phase (participant does not trigger the ventilator cycle sustainly) in which ASV and Pressure-Control Ventilation will be performed in a randomized order. The second phase will be the active ventilation phase (participant does trigger the ventilator cycle sustainly) in which ASV and Pressure-Support Ventilation will be performed in a randomized order.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Lausanne, Switzerland, 1011
        • Lausanne University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 10 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • children on invasive mechanical ventilation admitted in the Pediatric Intensive Care Unit at Lausanne University Hospital
  • Body weight > 6kg
  • Absence of pulmonary comorbidity
  • Age < 10 years

Exclusion Criteria:

  • Patient already included in other interventional clinical study
  • body weight < 6kg
  • age > 10 years
  • more than 20% of air leak around endotracheal tube
  • chronic or acute pulmonary disease (ARDS, cystic fibrosis, severe asthma, lobectomy, severe bronchomalacia or severe tracheomalacia)
  • severe pulmonary hypertension on inhaled nitric oxide treatment
  • severe hemodynamic instability (more than 0.5mcg/kg/min of norepinephrine infusion or other high dose vasoactive agent infusion)
  • intracranial hypertension (more than 20mmHg if measured) or suspected intracranial hypertension

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Passive phase, Pressure-Control Ventilation / ASV order
90 minutes of Pressure-Control Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV. Return to Pressure-Control Ventilation mode at the end of the intervention.
Ventilation on ASV mode
Experimental: Passive phase, ASV / Pressure-Control Ventilation order
90 minutes of ASV, change to Pressure-Control Ventilation mode with 15 to 30 minutes of washout, 90 minutes of Pressure-Control Ventilation.
Ventilation on ASV mode
Experimental: Active phase, Pressure-Support / ASV order
90 minutes of Pressure-Support Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV. Return to Pressure-Support Ventilation at the end of the intervention.
Ventilation on ASV mode
Experimental: Active phase, ASV / Pressure-Support order
90 minutes of ASV, change to Pressure-Support Ventilation with 15 to 30 minutes of washout, 90 minutes of Pressure-Support Ventilation.
Ventilation on ASV mode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of respiratory rate
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Change of tidal volume
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Change of peak inspiratory pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of Minute Ventilation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of Mean airway pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of inspiratory time
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of ratio inspiratory time/expiratory time
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of Crs (respiratory system compliance calculated by the ventilator)
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of respiratory system resistance
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of respiratory system time constant
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of positive end expiratory pressure (PEEP)
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of the variation of respiratory rate
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of the variation of peak inspiratory pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of end-tidal CO2
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of the variation of end-tidal CO2
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of transcutaneous CO2
Time Frame: Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
Evolution of variation of transcutaneous CO2
Time Frame: Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
Evolution of inspired oxygen fraction
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of variation of inspired oxygen fraction
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of transcutaneous oxygen saturation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of variation of transcutaneous oxygen saturation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of the work load of mechanical ventilation for doctor
Time Frame: monitoring phase of 90 minutes
Recording of all modification done on ventilator parameters done by doctor during each monitoring phase
monitoring phase of 90 minutes
Evolution of mechanical ventilation tolerance
Time Frame: monitoring phase of 90 minutes
Recording of all sedation drugs administered to the participant during each monitoring phase
monitoring phase of 90 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Ferry, MD, Lausanne University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2019

Primary Completion (Actual)

December 5, 2023

Study Completion (Actual)

December 5, 2023

Study Registration Dates

First Submitted

April 12, 2019

First Submitted That Met QC Criteria

April 25, 2019

First Posted (Actual)

April 29, 2019

Study Record Updates

Last Update Posted (Estimated)

December 13, 2023

Last Update Submitted That Met QC Criteria

December 12, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ASV ventilation in children

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanical Ventilation

Clinical Trials on ASV ventilation

3
Subscribe